» Articles » PMID: 23670541

Microtubule Alterations Occur Early in Experimental Parkinsonism and the Microtubule Stabilizer Epothilone D is Neuroprotective

Overview
Journal Sci Rep
Specialty Science
Date 2013 May 15
PMID 23670541
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

The role of microtubule (MT) dysfunction in Parkinson's disease is emerging. It is still unknown whether it is a cause or a consequence of neurodegeneration. Our objective was to assess whether alterations of MT stability precede or follow axonal transport impairment and neurite degeneration in experimental parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57Bl mice. MPTP induced a time- and dose-dependent increase in fibres with altered mitochondria distribution, and early changes in cytoskeletal proteins and MT stability. Indeed, we observed significant increases in neuron-specific βIII tubulin and enrichment of deTyr tubulin in dopaminergic neurons. Finally, we showed that repeated daily administrations of the MT stabilizer Epothilone D rescued MT defects and attenuated nigrostriatal degeneration induced by MPTP. These data suggest that alteration of ΜΤs is an early event specifically associated with dopaminergic neuron degeneration. Pharmacological stabilization of MTs may be a viable strategy for the management of parkinsonism.

Citing Articles

Emerging roles for tubulin PTMs in neuronal function and neurodegenerative disease.

Teoh J, Bartolini F Curr Opin Neurobiol. 2025; 90:102971.

PMID: 39862522 PMC: 11839326. DOI: 10.1016/j.conb.2025.102971.


Effects of Epothilone D on Social Defeat Stress-induced Changes in Microtubule-related and Endoplasmic Reticulum Stress Protein Expression.

Le T, Li L, Rami F, Oh J, Chun S, Chung Y Clin Psychopharmacol Neurosci. 2025; 23(1):110-119.

PMID: 39820117 PMC: 11747728. DOI: 10.9758/cpn.24.1212.


Evaluating the Role of Lin-11, Isl-1, and Mec-3 Kinases in Dopaminergic Neurodegeneration in a Subacute 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson's Disease.

Bhardwaj K, Roy A, Guha L, Kumar H ACS Pharmacol Transl Sci. 2024; 7(12):3879-3888.

PMID: 39698285 PMC: 11651167. DOI: 10.1021/acsptsci.4c00423.


Initial Molecular Mechanisms of the Pathogenesis of Parkinson's Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease.

Kolacheva A, Pavlova E, Bannikova A, Bogdanov V, Ugrumov M Int J Mol Sci. 2024; 25(2).

PMID: 38279354 PMC: 10816442. DOI: 10.3390/ijms25021354.


Linking acetylated α-Tubulin redistribution to α-Synuclein pathology in brain of Parkinson's disease patients.

Mazzetti S, Giampietro F, Calogero A, Isilgan H, Gagliardi G, Rolando C NPJ Parkinsons Dis. 2024; 10(1):2.

PMID: 38167511 PMC: 10761989. DOI: 10.1038/s41531-023-00607-9.


References
1.
Katsetos C, Herman M, Mork S . Class III beta-tubulin in human development and cancer. Cell Motil Cytoskeleton. 2003; 55(2):77-96. DOI: 10.1002/cm.10116. View

2.
He Y, Yu W, Baas P . Microtubule reconfiguration during axonal retraction induced by nitric oxide. J Neurosci. 2002; 22(14):5982-91. PMC: 6757941. DOI: 20026604. View

3.
Hastings T, Lewis D, Zigmond M . Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci U S A. 1996; 93(5):1956-61. PMC: 39890. DOI: 10.1073/pnas.93.5.1956. View

4.
Choi W, Palmiter R, Xia Z . Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson's disease model. J Cell Biol. 2011; 192(5):873-82. PMC: 3051820. DOI: 10.1083/jcb.201009132. View

5.
Hellal F, Hurtado A, Ruschel J, Flynn K, Laskowski C, Umlauf M . Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury. Science. 2011; 331(6019):928-31. PMC: 3330754. DOI: 10.1126/science.1201148. View